NCT01504893

Brief Summary

The purpose of this study is to determine if a protective ventilatory strategy during one-lung ventilation (OLV) based on low tidal volume, PEEP and alveolar recruitment maneuver can reduce Acute Respiratory Distress Syndrome (ARDS) and Postoperative pulmonary complications (PPCs) after major pulmonary resection. Primary endpoint: Evaluation of postoperative ARDS incidence Secondary endpoint: Evaluation od PPC incidence and postoperative outcomes (other complications, unplanned Intensive Care Admission, hospital and ICU length of stay, in-hospital mortality)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
984

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

16 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 6, 2012

Completed
1.7 years until next milestone

Study Start

First participant enrolled

September 1, 2013

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

December 2, 2022

Status Verified

November 1, 2022

Enrollment Period

2.9 years

First QC Date

December 30, 2011

Last Update Submit

November 29, 2022

Conditions

Keywords

One lung ventilationPEEPthoracic surgerylobectomy and pneumonectomyARDS

Outcome Measures

Primary Outcomes (1)

  • Acute Respiratory Distress Syndrome (ARDS) incidence

    incidence of ARDS (%)

    Hospital stay (7 days average expected)

Secondary Outcomes (6)

  • Postoperative pulmonary complications (PPCs)

    Hospital stay (7 days average expected)

  • In-hospital mortality

    Hospital stay (7 days average aspected)

  • Postoperative complications

    Hospital stay (7 days average expected)

  • Unplanned Intensive Care Unit (ICU) admission

    Hospital stay (7 days average aspected)

  • Intensive Care Unit (ICU) Length of stay

    Hospital stay (7 days average aspected)

  • +1 more secondary outcomes

Study Arms (2)

Protective

EXPERIMENTAL

Two-lung ventilation (TLV): tidal volume = 8 mL / kg PBW, peak airway pressure ≤ 25 cm H2O, I: E = 1:2; after lung re-expansion to the closure of the chest will set a PEEP of 5 cmH2O OLV (OLV): 4 mL / kg PBW, peak airway pressure ≤ 35 cmH2O, respiratory rate \<30, I:E = 1:2 / 1:3. During OLV in case of desaturation (before increasing the FiO2) and every 60 minutes alveolar recruitment maneuvers followed by the setting of PEEP to 5 cmH2O

Procedure: Protective one lung ventilation

Conventional

NO INTERVENTION

Two-lung ventilation (TLV): tidal volume = 8 mL / kg PBW, peak airway pressure ≤ 25 cmH2O; I: E = 1:2; after lung re-expansion to the closure of the chest PEEP set to 5 cmH2O OLV (OLV): 6 mL / kg PBW, peak airway pressure ≤ 35 cmH2O; I: E = 1:2.

Interventions

Low tidal volume, PEEP and alveolar recruitment maneuver

Protective

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients ≥ 18 years
  • ASA IV
  • Elective thoracotomies or thoracoscopic major lung resection surgery (lobectomy, bilobectomy, pneumonectomy)

You may not qualify if:

  • Emergency surgery
  • Wedge resection or atypical resection
  • Non-resective lung surgery requiring OLV
  • Patients \< 18 years
  • BMI \< 20 and BMI \> 29
  • Heart disease with ejection fraction \<50% and/or severe valvulopathy
  • Pulmonary hypertension
  • Renal failure requiring dialytic treatment
  • Drug addiction
  • Mental retardation, depression and psychiatric disease
  • Motor or sensory deficit
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (16)

ASST Papa Giovanni XXIII

Bergamo, Italy

Location

IRCCS Policlinico Sant'Orsola-Malpighi

Bologna, Italy

Location

Ospedale Centrale

Bolzano, Italy

Location

Azienda Ospedaliera Brotzu - Ospedale Oncologico Businco

Cagliari, Italy

Location

IRCCS Ospedale Policlinico San Martino

Genova, Italy

Location

Fondazione IRCCS Istituto Nazionale Tumori

Milan, Italy

Location

IRCCS Ospedale San Raffaele

Milan, Italy

Location

Azienda Ospedaliera-Universitaria

Modena, Italy

Location

Istituto Nazionale Tumori Fondazione Pascale

Napoli, Italy

Location

Azienda Ospedaliero-Universitaria

Padua, Italy

Location

IRCCS Centro di Riferimento Oncologico della Basilicata

Rionero in Vulture, Italy

Location

Istituto Nazionale Tumori Regina Elena

Rome, Italy

Location

Azienda Ospedaliera Universitaria Senese

Siena, Italy

Location

Ospedale di Cattinara

Trieste, Italy

Location

Department of Anesthesia and Intensive Care Unit

Udine, 33100, Italy

Location

Ospedale di Circolo e Fondazione Macchi

Varese, Italy

Location

Related Publications (2)

  • Yang M, Ahn HJ, Kim K, Kim JA, Yi CA, Kim MJ, Kim HJ. Does a protective ventilation strategy reduce the risk of pulmonary complications after lung cancer surgery?: a randomized controlled trial. Chest. 2011 Mar;139(3):530-537. doi: 10.1378/chest.09-2293. Epub 2010 Sep 9.

    PMID: 20829341BACKGROUND
  • Licker M, Diaper J, Villiger Y, Spiliopoulos A, Licker V, Robert J, Tschopp JM. Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery. Crit Care. 2009;13(2):R41. doi: 10.1186/cc7762. Epub 2009 Mar 24.

    PMID: 19317902BACKGROUND

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Giorgio Della Rocca, MD, Prof

    Azienda Ospedaliero-Universitaria S. Maria della Misericordia - Udine. Italy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

December 30, 2011

First Posted

January 6, 2012

Study Start

September 1, 2013

Primary Completion

August 1, 2016

Study Completion

September 1, 2017

Last Updated

December 2, 2022

Record last verified: 2022-11

Locations